Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF)

Clinical Endocrinology

Volumn 49, Issue 1, 1998, Pages 85-89

  De Leo, V ^a   La Marca, A ^a   Lanzetta, D ^a   Cariello, P L ^a   D'Antona, D ^a   Morgante, G ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FLUTAMIDE;

ADRENAL FUNCTION; ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RECEPTOR BLOCKING; ULTRASOUND;

17-ALPHA-HYDROXYPROGESTERONE; ADRENOCORTICOTROPIC HORMONE; ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; ANDROSTENEDIONE; AREA UNDER CURVE; CORTICOTROPIN-RELEASING HORMONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FLUTAMIDE; HUMANS; HYDROCORTISONE; PITUITARY-ADRENAL SYSTEM; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 0031821045     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00483.x     Document Type: Article

References (29)

1. Azziz, R., Gay, F.L., Potter, S.R., Bradley Jr, E. & Boots, L.R. (1991) The effects of prolonged hypertesteronemia on adrenocortical biosynthesis in oophorectomized women. Journal of Clinical Endocrinology and Metabolism, 72, 1025-1030.
2. Barnes, R. & Rosenfield, R.L. (1989) The polycystic ovary syndrome: pathogenesis and treatment. Annals of Internal Medicine, 100, 386-399.
3. Brodgen, R.N. & Clissod, S.P. (1989) Flutamide, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer. Drugs, 38, 185-203.
4. Calandra, R.S., Purvis, K., Naess, O., Attramadal, A., Djoseland, O. & Hansson, V. (1978) Androgen receptors in the rat adrenal gland. Journal of Steroid Biochemistry, 9, 1009-1015.
5. Clos, V., Esteve, A., Jane, F. & Salva, P. (1988) Microsomial effects of cyproterone acetate and flutamide in rat testis. General Pharmacology, 19, 393-397.
6. Couzinet, B., Pholsena, M., Young, J. & Schaison, G. (1993) The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism. Clinical Endocrinology, 39, 157-162.
7. Cusan, L., Dupont, A., Belanger, A., Tremblay, R.R., Manhes, G. & Labrie, F. (1990) Treatment of hirsutism with the pure antiandrogen flutamide. Journal of the American Academic of Dermatology, 23, 462-469.
8. Ehrmann, D.A. & Rosenfield, R.L. (1990) Clinical review, an endocrinologic approach to the patient with hirsutism. Journal of Clinical Endocrinology and Metabolism, 71, 1-4.
9. Fruzzetti, F., De Lorenzo, D., Ricci, C. & Fioretti, P. (1993) Clinical and endocrine effects of flutamide in hyperandrogenic women. Fertility and Sterility, 60, 806-813.
10. Gibson, M., Lackritz, R., Schiff, I. & Tulschinski, D. (1977) Abnormal adrenal responses to adrenocorticotropin hormone in hyperandrogenic women. American Journal of Obstetrics and Gynecology, 127, 594-598.
11. Gilling-Smith, C. & Franks, S. (1993) Polycystic ovary syndrome. Reproductive Medicine Review, 2, 15-32.
12. Goldzieher, J.W. (1981) Polycystic ovarian disease. Fertility and Sterility, 35, 371-394.
13. Gomez, J.L., Dupont, A., Cusan, L., Tremblay, M., Suburu, R., Lemay, M. & Labrie, F. (1992) Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. American Journal of Medicine, 92, 465-470.
14. Hammerstein, J., Meckies, J., Leo-Rossberg, I., Moltz, L. & Zielske, F. (1975) Use of cyproteone acetate in the treatment of acne, hursutism and virilism. Journal of Steroid Biochemistry, 6, 827-836.
15. Hatch, R., Rosenfield, R., Kim, M.H. & Tredway, D. (1981) Hirsutism: implications, etiology, and management. American Journal of Obstetrics & Gynecology, 140, 815-826.
16. Hirst, J.J., West, N.B., Brenner, R.M. & Novy, M.J. (1992) Steroid hormone receptors in the adrenal glands of fetal and adult rhesus monkeys. Journal of Clinical Endocrinology and Metabolism, 75, 308-314.
17. Labrie, F., Dupont, A. & Belanger, A. (1987) LHRH agonists and antiandrogens in prostate cancer. In Genitourinary Cancer (eds. T.L. Ratlift & W.J. Catalona), pp. 157-200. Martinus Nijhoff Publisher, Boston.
18. Marcondes, J.A., Minnani, S.L., Luthold, W.W., Wajchenberg, B.L., Samojlik, E. & Kirschner, M.A. (1992) Treatment of hirsutism in women with flutamide. Fertility and Sterility, 57, 543-547.
19. Marugo, M., Bernasconi, D., Meozzi, M., Del Monte, P., Zino, V., Primarolo, P. & Badaracco, B. (1994) The use of flutamide in the management of hirsutism. Journal of Endocrinological Investigation, 17, 195-199.
20. Messina, M., Manien, C., Biffignandi, P., Massuchetti, C., Novi, R.F. & Molinatti, G.M. (1983) Antiandrogen properties of spironolactone. Clinical trial in the management of female hirsutism. Journal of Endocrinological Investigation, 6, 23-27.
21. Muderris, I.L., Bayram, F., Sahin, Y., Kalestimur, F., Tutus, A. & Ayata, D. (1996) The efficacy of 250mg/day flutamide in the treatment of patients with hirsutism. Fertility and Sterility, 66, 220-222.
22. Neri, R., Florance, K., Koziol, P. & Van Cleave, S. (1972) A biological profile of a nonsteroidal antiandrogen, SCH13521(4-nitro-3-trifluoromethyl-isobuty-ranilide). Encocrinology, 92, 427-137.
23. Phillips, G.B. (1996) Relationship between serum dehydroepiandrosterone sulfate, androstenedione and sex hormones in men and women. European Journal of Endocrinology, 134, 201-206.
24. Polderman, K.H., Gooren, L.J.G. & van der Veen, E.A. (1994) Testosterone administration increases adrenal response to adrenocorticotrophin. Clinical Endocrinology, 40, 595-601.
25. Polderman, K.H., Gooren, L.J.G. & van der Veen, E.A. (1995) Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clinical Endocrinology, 43, 415-421.
26. Purves, R.D. (1992) Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). Journal of Pharmacokinetics and Biopharmaceutics, 20, 211-226.
27. Tremblay, R.R. (1986) Treatment of hirsutism with spironolactone. Journal of Clinical Endocrinology and Metabolism, 15, 363-371.
28. Vermesh, M., Silva, P.D., Rosen, G.F., Vijod, A.G. & Lobo, R.A. (1988) Effect of androgen on adrenal steroidogenesis in normal women. Journal of Clinical Endocrinology and Metabolism, 66, 128-130.
29. Yen, S.S.C (1980) The polycystic ovary syndrome. Clinical Endocrinology, 12, 177-207.